(Q33613016)

English

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

author name string

Claus Christiansen

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Charles H Chesnut

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jonathan D Adachi

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Jacques P Brown

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

César E Fernandes

5

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Annie Wc Kung

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Santiago Palacios

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Amy B Levine

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Arkadi A Chines

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Ginger D Constantine

10

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

22 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

BMC Musculoskeletal Disorders

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

130

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

22 June 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

The search for the ideal SERM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Developing a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Epidemiology of osteoporotic fractures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908075

21 June 2018

Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-130

21 January 2018

Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-130

21 January 2018

Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-130

21 January 2018

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-130

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-130

21 January 2018

Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-11-130

21 January 2018

Adverse events reported by postmenopausal women in controlled trials with raloxifene

1 reference

https://pubmed.ncbi.nlm.nih.gov/20569451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20569451

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2474-11-130

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33613016&oldid=2195567512"